Bette  Caan  to  Patient Selection
                            
                            
                                This is a "connection" page, showing publications  Bette  Caan  has written about  Patient Selection.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.352
         
        
        
     
 
    
        
        - 
            Facebook advertising for recruitment of midlife women with bothersome vaginal symptoms: A pilot study. Clin Trials. 2019 10; 16(5):476-480.
            
            
                Score: 0.145
            
         
        
        - 
            Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008 Nov 19; 100(22):1581-91.
            
            
                Score: 0.070
            
         
        
        - 
            The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Ann Epidemiol. 2003 Oct; 13(9 Suppl):S87-97.
            
            
                Score: 0.049
            
         
        
        - 
            Research priorities in cancer cachexia: The University of Rochester Cancer Center NCI Community Oncology Research Program Research Base Symposium on Cancer Cachexia and Sarcopenia. Curr Opin Support Palliat Care. 2017 Dec; 11(4):278-286.
            
            
                Score: 0.033
            
         
        
        - 
            Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause. 2014 Jan; 21(1):45-58.
            
            
                Score: 0.025
            
         
        
        - 
            Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: the MsFLASH experience. Contemp Clin Trials. 2013 May; 35(1):25-34.
            
            
                Score: 0.024
            
         
        
        - 
            Response rates among control subjects in case-control studies. Ann Epidemiol. 1995 May; 5(3):245-9.
            
            
                Score: 0.007